Last week the Federal Circuit Court handed down what seemed to many a funny decision: that human genes are patentable. Myriad Genetics owns patents for two tumor suppressor genes, BRCA1 and BRCA2 (mutations of these genes are correlated with increased incidence of breast cancer, making them of great interest to doctors and scientists). Myriad was sued by doctors and researchers who claim that genes fall into the category of “products of nature,” which makes them unpatentable, but the court disagreed.
Posts tagged with: David Carey
In the Last Week
- The New Legalism: Missional, Radical, Narcissistic, and Shamed (1,455 views)
by Anthony Bradley - One Man's Great Escape from North Korea (506 views)
by Ray Nothstine - Should We Be Eating More Bugs? (450 views)
by Joe Carter - Obama Administration Orders Colleges to Implement Unconstitutional Speech Codes (335 views)
by Joe Carter - What capitalists can learn from Pope Francis (312 views)
by Elise Hilton
- Acton Commentary (256)
- Acton Media (76)
- Acton University (46)
- Bible and Theology (575)
- Christian Social Thought (243)
- Economic Freedom (69)
- Economics (102)
- General (584)
- Individual Liberty (163)
- Interviews (26)
- News and Events (2307)
- On Call in Culture (50)
- Poverty (114)
- PowerBlog Ramblings (53)
- PowerLinks (114)
- Programs (64)
- Public Policy (2054)
- Publications (212)
- Religious Liberty (31)
- Shareholder Activism (3)
- Shareholder Proxy Resolutions (3)
- Technology (15)
- Vatican (225)
- Virtue (47)
- Vocation (2)